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γ-glutamylcysteine synthetase (Gcs) is a vital enzyme catalyzing the ﬁrst and rate limiting step in the
trypanothione biosynthesis pathway, the ATP-dependent ligation of L-Glutamate and L-Cysteine to form
gamma-glutamylcysteine. The Trypanothione biosynthesis pathway is unique metabolic pathway es-
sential for trypanosomatid survival rendering Gcs as a potential drug target. Here we report the cloning,
expression, puriﬁcation and characterization of L. donovani Gcs. Three other constructs of Gcs (GcsN,
GcsC and GcsT) were designed on the basis of S. cerevisiae and E. coli Gcs crystal structures. The study
shows Gcs possesses ATPase activity even in the absence of substrates L-glutamate and L-Cysteine. Di-
valent ions however plays an indispensable role in LdGcs ATPase activity. Isothermal titration calorimetry
and ﬂuorescence studies illustrates that L. donovani Gcs binds substrate in order ATP 4L-glutamate4L-
cysteine with Glu 92 and Arg 498 involved in ATP hydrolysis and Glu 92, Glu 55 and Arg 498 involved in
glutamate binding. Homology modeling and molecular dynamic simulation studies provided the struc-
tural rationale of LdGcs catalytic activity and emphasized on the possibility of involvement of three Mg2þ
ions along with Glutamates 52, 55, 92, 99, Met 322, Gln 328, Tyr 397, Lys 483, Arg 494 and Arg 498 in the
catalytic function of L. donovani Gcs.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Visceral leishmaniasis (VL) is the most devastating and fatal
form of leishmaniasis caused primarily by the parasitic protozoan
Leishmania donovani, leading to an estimated 300,000 new cases of
disease annually with more than 20,000 deaths [1]. Co-infection
with HIV results in a signiﬁcant increase in VL pervasiveness [2].
The disease is prevalent throughout the tropical world and current
drug treatment regimen have limitations due to toxicity, high cost,
difﬁcult dosage regime and development of resistance to anti-
monial drugs. These drawbacks have severely reduced the options
for clinical treatment of VL and till date no effective drug or vac-
cine is available. The crucial step in the development of the new
drug in a rationale-driven drug discovery approach is the identi-
ﬁcation, functional and structural characterization of a protein or a
pathway in the pathogen that is either absent or sufﬁciently dif-
ferent from its host. One such pathway is the trypanothionean open access article under the C
and Molecular Biophysics,
is, MO 6311063110, USA.biosynthesis pathway [3–6]. Trypansomatids including Leishmania
utilize a potent machinery employing the bis glutathione-sper-
midine conjugate trypanothione, as a major thiol along with uni-
versally present thiol glutathione. In the absence of the ubiqui-
tously present enzymes catalase and glutathione peroxidase which
are responsible for neutralizing reactive oxygen species (ROS) in
other organisms, trypanothione plays a crucial role in ﬁghting
large amount of reactive oxidative species (ROS) generated by the
macrophages during the initial phase of parasite–host interactions
in trypanosomatids [7–10].
Independently synthesised glutathione and spermidine con-
jugate to form trypanothione. Glutathione biosynthesis takes place
in two steps : the ﬁrst step, catalysed by γ-glutamylcysteine syn-
thetase (Gcs EC 6.3.2.2) is the ATP-dependent ligation of L-Cy-
steine to L-Glutamate to form γ-glutamylcysteine [11]; the second
step is the conjugation of L-glycine forming glutathione, catalysed
by glutathione synthetase in an ATP dependent manner [12].
Spermidine is obtained from putrescine in the reactions catalyzed
by ornithine decarboxylase and spermidine synthase. The next
two steps resulting in trypanothione biosynthesis are unique to
trypanosomatids wherein glutathione couples with spermidine
resulting in the formation of glutathionyl spermidine [4], to whichC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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nothione. The former reaction is catalysed by the enzyme glu-
tathionyl spermidine synthetase (EC 6.3.1.8) while the latter is
catalysed by trypanothione synthetase (EC 6.3.1.9) [13].
Among the enzymes involved in trypanothione biosynthesis
pathway, Gcs catalyses the initial and rate-limiting step in glu-
tathione synthesis and plays an indispensable role in the survival
of the organism [14,15]. Null mutants of Gcs in fungi, mammals,
Trypanosoma brucei (T. brucei) and also in Leishmania infantum (L.
infantum) could not survive unless rescued by exogenous glu-
tathione [16–22]. The high resistance of human neuroblastoma
cells against oxidative damage, has been correlated with the
higher expression levels of Gcs at mRNA and protein (catalytic
subunit) level [23]. L-buthionine-S, R-sulfoximine (BSO), a speciﬁc
inhibitor of Gcs cures and prolongs survival of mice infected with
T. brucei implicating Gcs as a potential drug target [24]. It was also
observed that vaccination with L. donovani Gcs (LdGcs) fusion
protein or DNA based vaccine provided protection against L. do-
novani infection in BALB/c mouse model which further validates
the pharmaceutical importance of Gcs [25,26].
Though an essential protein in all class of organisms, Gcs se-
quences show signiﬁcant diversity and can be categorized into
three distinct phylogenetic groups - the ﬁrst group consists of Gcs
from proteobacteria like E. coli, the second group contains non-
plant eukaryotes such as Homo sapiens, Saccharomyces cerevisiae
and trypanosomatids while the third group consists of alpha-
proteobacteria and plants such as Pisum sativum and Glycine max
[27]. Despite having insigniﬁcant pairwise sequence identities
(o10%) between these groups, the structures share a core archi-
tecture comprised of 6 antiparallel β-strands surrounded by an α-
helix [28–30].
LdGcs belongs to the second group sharing signiﬁcant sequence
identity with Saccharomyces cerevisiae Gcs (ScGcs), whose crystal
structure had been elucidated. Further, residues essential for metal
binding and catalysis have also been determined using structural
information gained from glutamine synthetase in T. brucei ortho-
log (TbGcs) [31–33]. The structural and functional knowledge
gained from ScGcs and TbGcs prompted us to study the active site,
substrate binding and catalytic features of LdGcs in comparison
with these organisms. Although recombinant full-length LdGcs has
been puriﬁed from inclusion bodies under denaturising condition
with 6 M urea, lack of a homogenous population has prevented
this study [25]. In the present manuscript, we report the cloning
and puriﬁcation of L. donovani Gcs full length (Gcs), 45 residues
N-terminal and 167 residue C-terminal truncated Gcs construct
(GcsT) retaining all functionally important residues, in its properly
folded and active conformation, and a C-terminal construct lacking
ﬁrst 291 residues (GcsC). The study provides ﬁrst biochemical,
biophysical and structural insights of LdGcs with the substrate
binding aspect rationalized using computational studies.2. Results and discussion
2.1. Sequence and phylogenetic analysis
Leishmania donovani Gcs (UniProt Accession No Q67BG), is a
member of the glutamylcysteine synthetase superfamily. PSI-
BLAST against the Protein Data Bank recommend S. cereviseae Gcs
(ScGcs) as the closest homologue with 31% sequence identity.
Pairwise alignment of LdGcs with H. sapiens Gcs catalytic subunit
and T. brucei Gcs shows 47% and 58% sequence identity respec-
tively. Multiple Sequence alignment of Gcs from L. donovani, T.
brucei, S. cereviseae, H. sapiens, B. juncea and E. coli shows that most
of the functional residues are conserved among L. donovani, S.
cerevisiae, T. brucei, while H. sapiens, while E. coli and B. juncea Gcsshow differences, consistent with Gcs sequence classiﬁcation stu-
dies (Fig. 1A). Interestingly, Cys 319, implicated in cystamine in-
activation of T. brucei Gcs, is not conserved in L. donovani and is
replaced by Asparagine. The other active site residues that differ in
L. donovani are Glu 52, Asn 324 and Ala 326 which are replaced by
Asp 49, Cys 264 and Cys 266 respectively (residue numbering as in
S. cereviseae).
Phylogenetic analysis shows three different clusters of Gcs
enzyme (Fig. 1B), validating the multiple sequence alignment
analysis. As can be seen from the analysis the second and third
groups of Gcs share the same evolutionary lineage while ﬁrst
group Gcs evolving earlier. Also amongst members of group two,
mammals, trypanosomatids, insects and yeast evolved distinctly
over the course of time.
The pair-wise sequence alignment of LdGcs with ScGcs se-
quence suggests most of the functional residues are distributed
within the central region (Supplementary Fig. 1) and therefore, a
construct consistent with this (GcsT, Residues 45 – 520) was also
designed in addition to the N- (Residues 1-291) and C- (Residues
292–697) terminal constructs named as GcsN and GcsC respec-
tively (Supplementary Fig. 1).
2.2. Cloning and puriﬁcation of GcsF, GcsT and GcsC
The L. donovani Gcs constructs were cloned, over-expressed and
puriﬁed using immobilized metal afﬁnity chromatography, and
conﬁrmed on a 10% SDS PAGE. While a band was observed at the
expected full length size of 78 kDa, other bands (to  45 kDa) are
also present (Fig. 2A) suggesting the recombinant GcsF is not
stable and degrades in 24 h (Fig. 2A). Consequently, the ex-
periments involving this construct were accomplished with
freshly puriﬁed protein. Size exclusion chromatography of GcsF
(Fig. 2B) shows that the recombinant protein is monomeric with
some higher order oligomer population. The presence of higher
order oligomers is probably observed for the ﬁrst time in LdGcs, as
other reported Gcs are monomers. The monomer population of
LdGcs was used for enzymatic studies.
The recombinant GcsT and the GcsC constructs after IMAC
puriﬁcation were observed at their expected sizes i.e., 52 kDa and
43 kDa (Fig. 2C, D) respectively, without any degradation. Func-
tional assays of the former two constructs were carried out after
size exclusion chromatography. Prior to functional assays being
carried out, GcsT and GcsC were analyzed for structural integrity
using Circular Dichorism as their puriﬁcation involved urea de-
naturation and both constructs showed properly folded structures
(Supplementary Fig. 2A-D).
2.3. ATPase activity
ATPase activity of GcsT and GcsC were studied by the protocol
given in Ohno et al. [34] using 1μCi 32P ATP. The Optimum ATPase
activity was displayed by 2.5 mM GcsT in buffer B in 40 min. Iso-
topic assays were carried out in the absence of the substrates L-
Glutamate and L-Cysteine validating GcsT possess substrate in-
dependent ATPase activity. Isotopic assays in presence of Mg2þ
displayed signiﬁcant enhancement of activity at 2 mM with max-
imum activity at 8 mM concentration above which it has in-
hibitory effect (Fig. 3A-B). NADH coupled assays also substantiate
this observation with comparable rise in ATPase activities in the
presence of 0.25–8 mM Mg2þ , with a signiﬁcant fall on further
increase in Mg2þ concentration.
The presence of magnesium increases ATPase activity by 8
fold. This encouraged us to determine the effect of other divalent
ions such as Mn2þ , Co2þ , Cd2þ , Cs2þ , Zn2þ Ca2þ on Gcs ATPase
activity. Isotopic assays recommend Mg2þ as most favorable di-
valent ion with Cobalt being second and manganese being third
Fig. 1. Phylogeny and sequence analysis (A) Multiple sequence alignment of γ-glutamylcysteine synthetase of S. cerevisiae, H. sapiens, T. brucei, L. donovani, B. juncea and E.
coli. Sequences were retrieved from Uniprot gene database with their Uniprot gene id given proceeding name in multiple sequence alignment. (B) Phylogenetic tree showing
three different classes of Gcs.
Fig. 2. Puriﬁcation of LdGcs. (A) 10% SDS PAGE of GcsF puriﬁcation samples Lane 1–5 correspond to unstained protein marker; cell lysate loaded on NiNTA column; ﬂow
through of NiNTA column; wash sample conataining 10 mM imidazole; wash sample containing 50 mM imidazole; lane 6–7 elution sample containing NiNTA puriﬁed Gcs;
right panel anti-His western blot of elution sample showing bands are degradation products of Gcs. (B) Size exclusion chromatography proﬁle of Gcs with elution volume
15.8 ml corresponding to reference protein conalbumin (75 kDa) showing molecular weight corresponding to monomer. Peak at 8.8 corresponds to molecular weight above
440 corresponding to higher order oligomer. (C) 10% SDS PAGE showing M, unstained standards; lanes 1 and 2, over-expression of GcsT (DE3) pre-induction (lane 1) and
post-induction (lane 2), with 1 mM IPTG. Lane 3, Western immunoblotting of over-expressed sample with anti-His antibody. Lane 4–5 puriﬁed GCST on 10% SDS PAGE (D)
10% SDS PAGE showing M unstained standards; lanes 1 and 2, over-expression of pET28a-GcsC (DE3) pre-induction and post-induction with 1 mM IPTG, M, prestained
protein molecular weight marker; lane 3, Puriﬁed GcsC at expected size 45 kDa.
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Fig. 3. Factors affecting ATPase activity Effect of MgCl2 on ATPase activity of GcsT (A) isotopic assay, (B) NADH coupled assay. The results were plotted as % relative activity
versus MgCl2 concentration. Optimum activity was found at 8 mM MgCl2.for GcsT. (C-D) Effect of divalent cations on ATPase activity. Extent of hydrolysis was plotted as
percentage activity as a function of individual divalent cations Mg2þ , Mn2þ , Co2þ , Cd2þ , Cs2þ , Zn2þ and Ca2þ . Mg2þ show maximum increase in ATPase activity. Inset
shows radiographs having Gcs with the same divalent cations. ATPase activity in presence of different concentrations (0.25–20 mM) of (E) Mn2þ and (F) Co2þ . The results
were plotted as % relative activity versus divalent concentration. Three independent experiments were performed and results were averaged for relative activity calculation.
Fig. 4. Dot blot assay for ATP binding. GcsT in buffer comprised of 50 mM Tris-HCl pH 8.5, 50 mM NaCl, 3 mM β-me and 4 mM MgCl2 was immobilized on a nitrocellulose
membrane and incubated with labeled 50 μM of γ32P ATP. (A) Nitrocellulose dot blot autoradiograph on X-ray ﬁlm, showing effect of increasing concentration of protein,
ATP and EDTA on ATP binding. (B) Intensity of spots representing bound radiolabelled ATP was plotted against increasing EDTA concentration. Bar diagram representing
decrease in ATP binding with increasing EDTA concentration. (C) Bar diagram showing increase in ATP binding with increasing protein concentration. (D) Bar diagram
showing displacement of radiolabeled ATP by unlabelled ATP as revealed by decrease in spot intensity.
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pled assays (Fig. 4D). The optimum concentrations of Mn2þ and
Co2þ were also determined. Mn2þ was found to increase ATPaseactivity up to 4 mM concentration, after which it exhibits in-
hibitory effect, with the corresponding value for cobalt being
8 mM (Fig. 3E and F). This is in agreement with earlier studies of
Table 1
Km and Vmax values were determined by the Michaelis-Menten equation. The
lineweaver burk plot was also considered for determining these paramerters.
Kmapp (mM) Vmaxapp (uM/min/mg)
ATP 6.257 .4 85.32
L-Glutamate 9.271.1 108.26
L-Cysteine 1.770.15 75.18
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latively lower concentrations than Mg2þ and has inhibitory effects
at higher concentration [32]. However, the optimum concentration
of Mn2þ was 0.75 mM in TbGcs unlike LdGcs where the optimum
concentration in 2 mM. The plausible explanation behind this
phenomenon lies in the fact that LdGcs possess three metal
binding sites, instead of two detected in TbGcs, as observed in
ScGcs crystal structure and corroborated with MD simulation
studies. These three metal binding sites can separately bind metal
ion alone or coordinated with substrates L-glutamate and ADP
[29]. Magnesium in lower concentrations plays a crucial role in
forming Mg-ATP complex and ATPase activity. However, at higher
concentrations the complex is disrupted leading to inhibitory ef-
fect on ATPase reaction. This observation is consistent with earlier
ﬁndings in other class of ATPase as well [35].2.4. Role of divalent ion in ATP binding
The role of divalent ion(s) in ATP binding of Gcs was further
validated by a ﬁlter based nucleotide binding assay. GcsT was
immobilized on a nitrocellulose membrane with increasing con-
centration of protein, EDTA, ATP and BSA (as control) and in-
cubated with 50 μM γ32P ATP. The autoradiographs in Fig. 4 A,C
clearly show increase in spot density with increasing protein
concentration, indicative of GcsT binding radiolabeled ATP. With
increasing concentrations of EDTA, the spot density decreases,
reafﬁrming the essential role of the divalent ion (Fig. 4B). Spot
density decreases in the presence of excess unlabelled ATP as a
result of competitive binding (Fig. 4D). As a control blotted BSA has
no spots.2.5. Kinetic parameters of ATPase activity
Kinetic parameters of L. donovani Gcs ATPase activity were
analyzed by simultaneously measuring ATPase activity in varying
concentrations of ATP, L-Glutamate and L-Cysteine with saturating
concentration of other two substrates using a NADH-coupled assay
as described in Materials and Methods section. The calculated
speciﬁc activity of GcsF was 19 units/mg protein, which is com-
parable to the reported value for rat Gcs (16 units/mg) [36] and
similar to the reported T. brucei Gcs (9.8 units/mg) [37] speciﬁc
activity. The LdGcs and its constructs have basal ATPase activity
even in the absence of L-glutamate and L-Cysteine. However, as
mentioned earlier, the presence of Mg2þ was crucial for ATPase
activity. Apparent Km and Vmax were determined to be in the milli
molar range (Fig. 5; Table 1).Fig. 5. Kinetic parameters of ATPase activity. (A) ATP; (B) L-Glutamate; (C) L-Cysteine. Ra
were obtained by the ﬁt of Michaelis-Menten equation in Prism 5.0 software. Lineweav2.6. Substrate binding
Gcs catalyzes the ATP-dependent ligation of L-glutamate and
L-cysteine and has a large active site to accommodate all three
substrates simultaneously. Despite the large active site, the bind-
ing and catalysis of substrates cannot be completely random. The
available structural and biochemical knowledge from homologous
Gcs [28–33] have shown signiﬁcant afﬁnity with both L-glutamate
and ATP and but the relative afﬁnities for these are still not clear.
Further, the binding afﬁnity of Gcs to L-cysteine is also not known
till date. To address these questions, a series of Isothermal titration
calorimetry (ITC) and intrinsic tryptophan ﬂuorescence quenching
studies were carried out. Results of the ITC experiment exemplify
that all interactions are thermodynamically favorable, with sig-
niﬁcant differences in relative afﬁnities. The binding afﬁnity of ATP
is 1000 fold higher then L-Glutamate which again has a 1000
fold higher afﬁnity than L-Cysteine (Fig. 6). This observation was
veriﬁed by tryptophan ﬂuorescence quenching studies as well
which shows a similar trend in binding order i.e., ATP"-
LGlutamate4L-Cysteine.
In a subsequent set of experiments, Gcs was incubated with
either ATP or L-glutamate and titrations carried out with the other
ligand (L-glutamate or ATP) to determine if the binding site is
shared between the ligands or a preferential order of binding, if
any. ITC studies of ATP bound Gcs with L-Glutamate and L-Gluta-
mate bound Gcs with ATP shows comparable Kd values in micro-
molar range (Table 2). This suggests that binding of these sub-
strates are independent of one another, validating the presence of
distinct binding sites of ATP and L-Glutamate, later validated by
computational studies. Further, binding afﬁnity of glutamate with
native Gcs is sufﬁciently lower than with Gcs-ATP complex fa-
voring the possibility of ATP endorsing glutamate binding. This
might also be the result of catalysis taking place due to the pre-
sence of two substrates. A similar experiment was carried out with
the enzyme incubated with ATP and L-glutamate and titrated
against the third substrate, Cysteine, but the results were incon-
clusive. GcsT and C-terminal constructs also show comparable
binding with ATP, though these constructs have a lower afﬁnity for
L-Glutamate and L-Cysteine (Table 2). The apparent Kd values of all
the substrates are summarized in Table 2.te of ADP formed was plotted against substrate concentration. Km and Vmax values
er Burk plot are shown in inset. All experiments were performed two times.
Fig. 6. Substrate binding of LdGcs. (A) Thermogram of binding of LdGcs, left, middle and right panel corresponds to ATP, L-Glutamate and L-Cysteine. 15 μM recombinant
protein in HEPES pH 7.5 was titrated against 200 μM of substrate. Kd values were obtained by ﬁtting the data using Origin 7.0 software. (B) Tryptophan ﬂuorescence
saturation binding isotherms of Gcs.
Table 2
Kd values of LdGcs obtained by ITC and tryptophan ﬂuorescence quenching studies.
LdGcs Kd μM (ITC) Kd μM (Tryptophan Fluorescence
quenching)
ATP 0.0005 2.7
L-Glutamate 0.25 93.7
L-Cysteine 204 177
Gcs(ATP) þ L-Glutamate 0.046 53
Gcs(L-Glutamate) þ ATP 0.032 22
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The residues essential for substrate binding and catalysis have
been determined from several homologous Gcs [28–33]. In the
absence of three dimensional structure of Gcs, the active site de-
terminants of nearest ortholog TbGcs has been determined earlier
with the aid of homology model based on structurally similar
protein glutamine synthase. The availability of ScGcs crystal
structure reinvigorated the determination of substrate binding and
catalysis determinants from LdGcs. Homology modeling was used
to build the L. donovani Gcs structure, to provide a structural ra-
tionale for the ligand binding aspects, using the S. cereviseae Gcs as
the template (details in Mat and Methods). The homology model
has a core fold similar to other members of the ATP-grasp super-
family with central β-sheet comprised of six antiparallel β-strands
surrounded by α-helices (Supplementary Fig. 3). The probable
binding site of ligands were obtained from the homologous ScGcs–ligand co-crystal structures [28,29] and 10 ns of molecular dy-
namics simulations were performed using Gromacs4.6 with
CHARMM force ﬁeld to obtain stable conformations for them. The
ligands undergo a minor conformational change over the simula-
tion that are summarized in Fig. 8. The root mean square (rms)
deviation plot of Cα residues over the simulation period clearly
shows that the complex is fairly stable with o1 nm deviation
throughout the simulation (Fig. 7A). The rms ﬂuctuation is still
lower o0.5 nm if residues 225–270, corresponding to loop region
are not included (Fig. 7B). Residues corresponding to this loop are
not present in the ScGcs structure and are distant from active site
pocket negating its involvement in catalytic mechanism of LdGcs.
Although the binding site for all the ligands were conﬁned to a
common cavity, the simulation conﬁrms that ATP and L-Glutamate
bind to distinct pockets, sharing some key binding residues some
of the residues involved in interaction were shared by ATP and
L-Glutamate (Fig. 8A; Table 3).
2.8. Nucleotide binding site
The nucleotide binding site of LdGcs can be explained on the
basis of ScGcs crystal structure with ADP (PDB ID 3IG8). 10 ns MD
simulation of LdGcs complex has shown slight change in the
conformation of adenine and sugar moiety of ADP while the
phosphate moiety was stable throughout the simulation (Fig. 7C,
D). The adenine ring is stabilized by hydrophobic interactions with
Ile 491, Lys 487. The ribose moiety interacts with Arg 494 through
one of the hydroxyl group. The phosphate moiety forms hydrogen
Fig. 7. MD simulation. (A) RMSD plot of Cα during MD trajectories of protein substrate complex. (B) root-mean-square ﬂuctuations during molecular dynamics trajectories
for proposed protein-substrate complex. Large RMS ﬂuctuation in residues 225–270 corresponds to loop region which is stabilized during simulation. The rmsd plot for
substrate ADP (C), L-cysteine (D) and L-glutamate (E) during 10 ns long simulation. (F) Relative positions of ligands in ScGcs crystal structure and LdGcs after simulation. The
ligands after simulation are shown as ADP (yellow), L-glutamate (green) and L-cysteine (Blue). The corresponding ScGcs conformations of ADP and L-glutamate are shown in
pale yellow and light green respectively.
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phate group as shown in Fig. 7. In LdGcs single Mg2þ ion co-or-
dinate the alpha and beta phosphate moiety through conserved
Glu 53and Glu 496 as shown in Fig. 8.
2.9. L-Glutamate binding Site
Our studies have shown that Gcs has the highest afﬁnity for
ATP, and can hydrolyze ATP even in the absence of L-Glutamate.
Also the afﬁnity of L-glutamate increases to ATP-Gcs complex than
Gcs alone, as evidenced from ITC experiments (Table 2). These
results suggests L-Glutamate probably binds to the site after ATP
binding and hydrolysis. MD simulation studies of all the three
substrates within the active site of LdGcs validates that the
L-glutamate binding pocket is comprised of Glu 53, Glu 55, Glu 92,
Glu 99, Met 322, Asn 328, Arg 367, Tyr 397 and Arg 498. L-Glu-
tamate is stabilized by hydrogen bond interaction with Glu 52 and
Tyr 397. The terminal carboxyl oxygen forms the hydrogen bond
with Tyr 397 while the amino group interacts directly with Glu 52.
These interactions are consistent with ScGcs crystal structure with
slight variation in side chains conformations of the interacting
residues (Fig. 8, Table 3). Two of three Mg2þ ion in LdGcs complex
were found to facilitate L-glutamate binding via coordination with
Glu 53, Glu 55, Glu 99 and Glu 92. The conserved residues corre-
sponding to Arg 373 and Arg 498 have been shown to inﬂuence L-
glutamate binding in TbGcs [33]. We later performed simulation
studies of LdGcs with phosphorylated glutamate and ADP. The10 ns MD simulation shows both phosphoglutamate and ADP are
stable within the LdGcs active site (Supplementary Fig. 4). The Arg
498 residues was found to interact with the phosphate moiety of
phosphorylated glutamate validating its essential role in LdGcs
activity (Supplementary Fig. 4). Detailed analysis of L-glutamate-
Gcs interactions throughout the simulation corroborates the con-
sistent involvement of Glu 92, Tyr 397, Arg 498, Met 322 and Gln
328 in the same order as observed in by the occupancy values of
their interaction with L-glutamate. This validates the direct in-
volvement of Glu 92, Met 322 and Gln 328 in addition to Tyr 397
and Arg 498 reported to determine L-glutamate binding in T.
brucei.2.10. L-Cysteine binding residues
L-Cysteine shows very weak or transient binding with Gcs. In
the ScGCS structure also, the cysteine moiety is not present
separately, but its relative orientation can be obtained from the
crystal structures of ScGcs with glutathione and BSO (PDB ID
3LVV and 3LVW), as they possess L-Cysteine moiety in them. MD
simulation studies shows Cysteine binding is weakly stabilized
by Glu 99 in LdGcs by interacting with the amino group of cy-
steine moiety (Figs. 7–8; Table 3). This interaction is conserved
throughout the MD simulation with an occupancy value of
87.23%.
Fig. 8. Substrate binding site of Gcs. Homology model of LdGcs (sea green) with the ligand binding region enhanced. In this ﬁgure, the ligands, L-Glutamate (green),
L-Cysteine (blue) and ADP (yellow) are shown in ball and stick , and residues that interact with these ligands are shown as sticks.
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Divalent ion plays an essential role in the functional mechan-
ism of LdGcs. The crystal structure of ScGcs clearly shows three
Mg2þ ions within the active site [29,30]. The presence of two
Mg2þ binding site has been veriﬁed for T. brucei Gcs [32]. We
considered the three Mg2þ ion along with ligands in our MD si-
mulation studies. The ﬁnal snapshot of protein after simulation
conﬁrms their presence with in LdGcs active site. The relative
position of two Mg2þ ions (M1 and M2) are similar to that ob-
served in ScGcs crystal structure while the third Mg2 ion (M3)
adopts a different position 41 Å away from that observed in
ScGcs (Fig. 8 and Table 3). In the ScGCS structure, both M2 and M3
are involved in coordinating ADP phosphate moiety while in LdGcs
only M2 co-ordinates with alpha and beta phosphate moieties of
ADP. Further in LdGcs in addition to M1, M2 ion also stabilizes
L-glutamate (Figs. 7–8). These different positions might be domi-
nant in different steps of catalysis.
The computational analysis clearly shows the importance of
Glutamates 52, 55, 92, 99, Tyr 397, Lys 483, Arg 494 and Arg 498 in
the function of L. donovani Gcs. Single mutants of these residues in
L. donovani GcsF and GcsT were designed using site directed mu-
tagenesis to conﬁrm their role in substrate binding. E55A, E92A,
E99A and R498A mutants of GcsF and GcsT have been cloned and
puriﬁed using a similar protocol as their native constructs.Substrate binding and ATPase activity of mutants were carried out
as before and the results show that out of these four residues E92
and R498 play a signiﬁcant role in ATP binding and hydrolysis, as
the corresponding Ala mutants possess a 30% reduction in their
relative ATPase activity with an enhanced Kd value (Fig. 9 and
Table 3). However, E55A and E99A mutants do not show much
variation in ATPase activity, although there is an 8 fold increase
in the apparent Kd (Table 4). The observations are similar in GcsT
single mutants as well though the deletion mutants have sig-
niﬁcantly lower activity than GcsF (Data not shown). This is in
agreement with our computational studies where Glu 55, and Arg
498 are involved in interaction with L-Glutamate while Glu 99
makes a Mg2þ dependent interaction.3. Conclusion
Gamma-glutamylcysteine synthetase is an essential enzyme of
L. donovanimetabolism. This manuscript reports the puriﬁcation of
L. donovani GcsF and its two constructs to homogeneity. Functional
assays shows that all the constructs puriﬁed are active with spe-
ciﬁc activity GcsF 19 units/mg. Detailed nucleotide binding and
hydrolysis studies shows that L. donovani possess substrate in-
dependent ATPase activity. Though, L-Glutamate and L-Cysteine
Table 3
Substrate binding residues and bonds in LdGcs and ScGcs.
LdGcs ScGcs
ADP Bond Distance (Å) Bond Distance (Å)
Gln 332 OE1-H…N6 3.3
Thr 101 OG1…. O2′ 4.0
Arg 481 NH2…. O2′ 2.9 Asp 49 O….. O3′ 2.8
Lys 483 NZ…. O2B 3.2 Lys 451 NZ…. O1B 3.9
Arg 498 NH2…. O3B 2.7
L-Glutamate Tyr 397 OH…OXT 2.6 Tyr 362 OH…OXT 3.0
Glu 92 OE1…N 2.7 Glu 52 OE2…N 3.7
Glu 92 OE2…N 3.4 Arg 472 NH2…OE2 3.1
3.18 Arg 472 NH1…OE2 3.9
L-Cysteine Glu 99 OE2…N 3.1 Glu 96 OE2…N 3.2
Glu 96 OE1…N 2.9
Trp 445 NE1…O 2.7
Mg2þ 1 Glu 53 OE1….. Mg 1.84 Glu 52 OE2….. Mg 2.19
Glu 55 OE1….. Mg 1.72 Glu 96 OE2….. Mg 2.22
Glu 99 OE2…Mg 1.79 Glu 103 OE1…. Mg 2.18
Glu OE2…. Mg 1.75 Glu OE2…Mg 2.02
Mg2þ 2 Glu 53 OE1…. Mg 1.8 Glu 50 OE1…. Mg 2.16
Glu 50 OE2…. Mg 2.77
Glu 496 OE2…Mg 1.8 Glu 470 OE2…Mg 2.17
ADP O2B….. Mg 1.85 ADP O2B….. Mg 2.17
ADP O2A….. Mg 1.87
Mg2þ 3 Glu 55 OE2…. Mg 1.86 Glu 50 OE2…. Mg 2.26
Glu 92 OE2…Mg 1.96 Glu 103 OE2…Mg 2.18
Glu O…. Mg 1.83 ADP O2A….. Mg 2.65
Glu OE1…. Mg 1.84 ADP O3B….. Mg 2.19
Fig. 9. Relative ATPase activity of LdGcs mutants obtained by NADH coupled assay.
The experiments were performed three times. GcsF activity was considered 100%
and relative activity of each construct was determined. Results shows 30% reduced
activity for E92A and R498A mutant revealing their role in ATP binding or
hydrolysis.
Table 4
Apparent Kd values of ATP, L-Glutamate and L-Cysteine for different mutants of
LdGcs. Kd values were calculated as mentioned in materials and methods.
Constructs Kd Value (μM)
ATP L-Glutamate L-Cysteine
GcsF 2.77 0.3 93.77 1.8 1777 2.6
E55A 2.571 7937 .182 9572.1
E92A 32357 .937 1077 .16 1157 .35
R498A 15507238 8907 .167 164713
E99A 5.87 .3 6667 .3 173713
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ATP hydrolysis. The Km value L-Glutamate and L-Cysteine were
9.2 and 1.7 mM respectively.Substrate binding studies reveals signiﬁcantly different Kd va-
lues of all three substrates. On the basis of Kd values, probable
order of substrate binding might be ATP "L-Glutamate 4L-Cy-
steine. This observation suggest that despite signiﬁcantly large
active site of Gcs binding of substrates is not random consistent
with substrate binding proposed by Biterova et al. [29]. Divalent
ions plays an exceptional role in ATP binding and thus ATPase
activity of L. donovani Gcs with Mg2þ being the most appropriate
divalent ion followed by Co2þ and Mn2þ . The proposed LdGcs
complex model was found stable during MD simulation studies,
suggesting the stable relative orientation of substrates within
LdGcs active site. The visual analysis of ﬁnal snapshot after MD
shows three Mg2þ ions similar to that observed in ScGcs crystal
structure. While the M1 and M2 binding sites are similar to that
observed in ScGcs crystal structure, M3 is involved in coordinating
L-glutamate instead of ADP. This observation proposes that during
different stages of catalysis the position of ﬁrst two Mg2þ ions is
constant while third Mg2þ while third Mg2þ might adopt differ-
ent position, or might be absent as observed in TbGcs [32]. Com-
putational studies were used to depict the active site architecture,
in comparative manner with the substrate bound crystal structure
of ScGcs. These studies show that most of the active site residues
of LdGcs are conserved with ScGcs.
The role of Glu 55, Glu 92, Glu 99 and Arg 498 in ATP binding
and hydrolysis was also studied. Mutation of Glu 92 and Arg 498
modestly decreased ATPase activity as well as binding. The Arg
498 has direct interaction with ADP while Glu 92 might be in-
volved in stabilizing γ-phosphate moiety ATP via Mg2þ ion. The
role of conserved Arg residue corresponding to Arg 498 has also
been veriﬁed in T. brucei as well as ScGcs [29,39]. L-Glutamate
binding requires Glu 55 in addition to Glu 92 and Arg 498 as
shown by 8fold increase in apparent Kd values of the mutants.
This in agreement with computational studies where Glu 55 and
Glu 92 clearly shows Mg2þ mediated interaction with L-glutamate
and Arg 498 lies within the hydrogen bonding distance.
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ScGcs [28,29] and the results obtained in this study were used to
explain the functional catalytic mechanism of L. donovani Gcs as
most residues are conserved. The catalytic mechanism can be
proposed to take place in three steps. The ﬁrst step involves
binding of ATP and its cleavage into ADP and subsequent activa-
tion of the γ-carboxyl group of L-Glutamate by released phosphate
to form a γ-glutamylphosphate intermediate. The released phos-
phate moiety might be co-ordinated and transferred to L-Gluta-
mate via Mg2þ ion making ATP hydrolysis possible even in ab-
sence of L-Glutamate. The second catalytic step involves nucleo-
philic attack of the amino group of L-Cysteine on the carbonyl
group of phosphorylated L-Glutamate to generate a tetrahedral
transition state [9,10]. In the third step the transition state re-
arranges to form gamma glutamylcysteine as product and phos-
phate moiety is released. The detailed role of all the residues needs
to be studied further by designing single and double mutants and
this information can be used for designing novel speciﬁc inhibitors
against L. donovani Gcs.
3.1. Experimental procedure
3.1.1. Computational analysis
The amino acid sequences of Gcs from L. donovani, H. sapiens, T.
brucei, S. cerevisiae, B. juncea, and E. coli were retrieved from the
UniProt data base (http://uniprot.org). The pairwise and multiple
sequence alignment were performed using CLUSTALW version 1.8
[40]. The evolutionary traces of LdGcs and members of all the
three classes of Gcs were studied by phylogenetic analysis with the
aid of MEGA 5.0 (Molecular Evolutionary Genetics Analysis) using
neighbor-joining methods with bootstrap test of phylogeny ap-
plying 500 bootstrap replications [41].
3.1.2. Cloning of L. donovani native GcsF and its deletion mutants
The coding regions of GcsF, GcsT, GcsC and GcsN 2 kb, 1.4 kb,
1.2 kb and 0.8 kb respectively were PCR ampliﬁed from the L. do-
novani genomic DNA using speciﬁc sense and anti-sense primers
designed with sites for NheI and BamHI restriction enzymes re-
spectively (Supplementary Table 1). The ampliﬁed PCR products
were cloned in T/A vector pTZ57R/T (InsTA cloneTM PCR cloning
kit, Fermentas International Inc.) and sub-cloned downstream
pET28a vector (Novagen). Clones were conﬁrmed by double di-
gestion and nucleotide sequencing. E. coli BL21 (DE3) host cell was
transformed with the recombinant plasmid pET28a and used for
over-expression.
3.1.3. Puriﬁcation of recombinant GcsF, GcsT and GcsC
E. coli BL21 (DE3) strain containing pET28a-Gcs constructs
clones were grown at 37 °C in Luria-Bertani (LB) broth supple-
mented with 50 mg/ml kanamycin to an OD600 of 0.5–0.6, induced
with 1 mM IPTG and grown further for 10–12h at 16 °C. Cells were
harvested and resuspended in 50 mM Tris-HCl pH 8.5 buffer,
200 mM NaCl (Buffer A) with 8 mM MgCl2 and lysed by sonication
and centrifuged at 12,000 rpm for 40 min and supernatant, in case
of GcsF, was loaded to NiNTA column pre-equilibrated with buffer
A. For GcsT and GcsC construct inclusion bodies collected in pellet
were resuspended in Buffer A with 2 M urea and incubated for 3 h
after which they were lysed, centrifuged and loaded on a Ni-NTA
column as earlier. The column was incubated for an hour and
subsequently washed twice with Buffer A containing 10 mM and
60 mM imidazole. Protein was then eluted in Buffer A with
300 mM imidazole. The eluted protein was dialyzed overnight into
buffer B (50 mM Tris-HCl pH 8.5, 50 mM NaCl, 3 mM β-me and
8 mMMgCl2) concentrated using 10 kDa cutoff centricon (Amicon)
and loaded on size exclusion chromatography for the second step
puriﬁcation and oligomerization analysis.The GcsN construct was insoluble even under denaturing
conditions and could not be used any further.
3.1.4. Size exclusion chromatography
Size-exclusion chromatography (SEC) experiments were per-
formed at 25 °C using a Superdex 200 10/300 pre-packed column
connected to an ÄKTA FPLC chromatograph (GE Healthcare). Ca-
libration of the column was performed using the high molecular
weight standard kit (GE Healthcare Cat No. 28-4038-42). 500 μl of
1 mg/ml protein was loaded in the column equilibrated with the
buffer B. The isocratic elution at a ﬂow rate of 0.3–0.4 ml/min was
carried out and proﬁles were recorded by monitoring absorbance
at 280 nm. The puriﬁed protein was concentrated as before and
utilized for further structural and biochemical characterization.
3.1.5. Determination of protein concentration
The protein concentration was determined by using Bradford
method [42]. The standard curve was plotted with bovine serum
albumin in the range of 0–22 mg/ml.
3.1.6. Isothermal titration calorimetry
The thermodynamic parameters of interaction were de-
termined by isothermal titration calorimetry (VP-ITC, Microcal,
Northampton, MA, USA). GcsF (13 μM) dialyzed in the buffer
containing HEPES pH 7.5, 300 mM NaCl and 8 mM MgCl2 was ti-
trated against 200 μM of substrate. The thermogram was analyzed
using Origin 7.0 software (Microcal, USA).
3.1.7. Fluorescence measurement
The intrinsic ﬂuorescence emission spectra for the three pro-
tein constructs (2 μM) were recorded on a Cary Eclipse ﬂuores-
cence spectrophotometer (Agilent Technologies) at 25 °C in 5 mm
path length cuvettes, with excitation at 295 nm and the emission
spectra recorded in the range 300–400 nm.
Steady-state ﬂuorescence experiments were performed using
identical protein concentration in buffer B and the change in
tryptophan ﬂuorescence spectra was observed at 339 nm with
increasing concentration of ligands. Titrations with buffer alone
were performed as control. The change in ﬂuorescence was then
related to binding of nucleotide by the following standard equa-
tion
⎡⎣ ⎤⎦ ⎡⎣ ⎤⎦( )Δ Δ =F Fmax substrate K substrate/ /tot d tot
Where, ΔF is the magnitude of the difference between the
observed ﬂuorescence intensity at a given concentration of sub-
strate and the ﬂuorescence intensity in the absence of substrate,
ΔFmax is the difference between the observed ﬂuorescence in-
tensities at zero and saturating substrate concentration], [Sub-
strate] tot and Kd is the apparent dissociation constant. The Kd
values were determined from non-linear least-squares regression
analysis of titration data. Fluorescence spectra with all samples
were corrected for the background ﬂuorescence of the solution
(buffer þ substrate). Deconvolution of curves was performed
using the Prism software (GraphPad Software, Inc., La Jolla, CA,
USA).
3.1.8. Circular dichroism measurements
The far-UV CD measurements were made on a Jasco J810
spectropolarimeter and Chirascan™ CD spectropolarimeter (Ap-
plied Photophysics) calibrated with ammonium (þ)10-cam-
phorsulfonate. The average of three spectra (200–260 nm, scan-
speed 10 nm/min) from 2 mM protein samples, dissolved in buffer
B was taken for far-UV CD spectra following standard protocols
[43,44].
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GcsT (1–5 μg) in Buffer B was immobilized on a nitrocellulose
membrane with increasing concentrations of BSA taken as nega-
tive control. The membrane was blocked with 2% BSA and then
incubated with 50 μM [γ-32P] ATP diluted in 2% BSA in PBS at 25 °C
for 25 min and then washed with PBS containing 0.5% Tween-20.
Autoradiogram of the blot was taken, and densitometry of the
spots was performed using alpha imager software (GE healthcare).
ATP binding was further conﬁrmed by incubating protein with
increasing concentration of unlabelled ATP ranging from 0 to
800 μM. The role of magnesium ion was also analyzed by in-
creasing concentration of EDTA (0–20 mM).
3.1.10. ATPase activity
The ATPase activity was carried out using radioactive and
NADH coupled assays. Isotopic ATPase reaction mixture (10 μl)
comprise 2.5 μM of protein in buffer B with 1 μCi of radiolabelled
γ-32P ATP as substrate. Effect of MgCl2 was studied in ATPase re-
action without MgCl2 at 25 °C. Reactions were stopped by adding
0.5 μl of 10% SDS. 1 μl of the reaction mixture was then spotted
onto a PEI-cellulose TLC plate (10 cm20 cm) and resolved in
0.5 M LiCl, 0.5 M formic acid and dried at 37 °C. The TLC plate was
auto radiographed and the released γ-32P was quantiﬁed using the
Image Master 1D Elite software (Amersham Biosciences). The
percentage of ATP hydrolysis was calculated using the formula.
Percentage of ATP hydrolysis ¼{quantity of [γ-32P] P /(quan-
tities of [γ-32P] P þ[γ-32P] ATP} x 100.
Background values (without protein) were subtracted. Opti-
mum protein concentration was identiﬁed by plotting released
γ-32P as a function of increasing protein concentration (0–5 μM),
the reaction was also setup with varying time at ﬁxed con-
centration of GcsT to ﬁnd out optimum time. The most suitable
divalent was explored by using different divalent in 2 mM con-
centration. Optimum magnesium concentration for ATPase reac-
tion was screened in the range of 0–20 mM.
Quantitative measurements of activity were done spectro-
photometrically at 340 nm by determining the rate of ADP for-
mation using a coupled assay with pyruvate kinase and lactate
dehydrogenase [45]. For determination of steady state kinetics
parameters, two substrates were ﬁxed at saturation and the third
substrate was varied in concentration. Km and Vmax values were
determined using Michaelis-Menten kinetics incorporated in
Prism 5.0 software (Graphpad Inc.).
3.1.11. Site directed mutagenesis
Site directed mutagenesis was carried out using standard PCR
based methods [46]. Primers for single mutations were designed
using Oligo software and are mentioned in supplementary table 2.
PET28a-GcsF and pET28a-GcsT were used as template for PCR
ampliﬁcation using pfu DNA polymerase (Fermentas International
Inc.). Ampliﬁed reaction product was digested with dpn1 (Fer-
mentas International Inc.) and transformed into E. coli DH5α
strain. Mutants were conﬁrmed by double digestion and
sequencing.
3.1.12. Homology modeling
Homology model was built using the crystal structure of Gcs from
S. cerevisiae (ScGcs) (PDB ID 3IG8) as the template identiﬁed from
Position speciﬁc iterative BLAST (Psi-BLAST) of LdGcs amino acid
sequence against sequences in the Protein Data Bank S. cerevisiae Gcs
(PDB ID: 3IG8) [29,30] was chosen as template, based on maximum
sequence identity and other statistical parameters. Homology models
were built using Modeller 9.10 [47], based on spatial restraints
method, using default parameters with pairwise sequence alignment
ﬁle of the target and template as input. Five models were obtained as
output for the full length Gcs as well as truncated construct. The top5 models were considered for visual analysis and they possess ac-
ceptable stereochemistry, with the  96% of the residues located in
the generously allowed regions. The models were ranked on the
basis of root mean square deviation (rmsd) and visual examination.
Models with minimum rmsd were used for further validation using
Molprobity and PROCHECK [48,49].
3.1.13. Molecular dynamic simulations
Substrate binding sites were obtained by extracting ligands
from ScGcs crystal structures (PDB ID- 3IG8, 3IG5 and 3LVW).
Molecular dynamic (MD) simulations and analysis were performed
using GROMACS 4.6.5 simulation package [50] adopting CHARMM
force ﬁeld parameters [51]. LdGcs homology model with ADP,
L-glutamate, L-cysteine and 3 Mg2þ ions was taken as starting
point for simulation. The topology of ligands ADP, L-glutamate and
L-cysteine were created using swissparam server [52]. The protein
ligand complex was solvated into a cubic box of TIP3P water
model. The complex was neutralized by using 18 Naþ ion. Energy
minimization was done using steepest descent method and con-
vergent crieteria of 10 KJ/Mol followed by dynamics simulations of
the whole system in the NVT and NPT ensemble at 293 K tem-
perature with a time step of 2 ps. The electrostatic interactions
were calculated using the Particle Mesh Ewald summation method
[53] while constraints were applied on all bonds using the LINCS
[54] algorithm. The equilibrated system was subjected to ﬁnal MD
production run of 10 ns. Root mean square deviation (RMSD) of Cα
residues and ligands and root mean square ﬂuctuation (RMSF) of
complex were calculated using g_rms and g_rmsf commands re-
spectively. Graphs were generated using Grace Program. The var-
ious frames generated were visually analyzed by Chimera 1.6.1
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